Noninvasive estimation of liver fibrosis and response to interferon therapy by a serum fibrogenesis marker, YKL-40, in patients with HCV-associated liver disease

AIM: To evaluate the clinical utility of serum fibrosis markers, including YKL-40, in patients with HCV-associated liver disease. METHODS: A total of 109 patients with HCV-associated liver disease were enrolled. We measured serum type IV collagen, amino-terminal peptide of type III procollagen (PIII...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:World J Gastroenterol
Autors principals: Saitou, Yukiko, Shiraki, Katsuya, Yamanaka, Yutaka, Yamaguchi, Yumi, Kawakita, Tomoyuki, Yamamoto, Norihiko, Sugimoto, Kazushi, Murata, Kazumoto, Nakano, Takeshi
Format: Artigo
Idioma:Inglês
Publicat: Baishideng Publishing Group Inc 2005
Matèries:
Viral Hepatitis
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4250794/
https://ncbi.nlm.nih.gov/pubmed/15641129
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3748/wjg.v11.i4.476
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars